Harmony Biosciences
HRMY
HRMY
241 hedge funds and large institutions have $2.78B invested in Harmony Biosciences in 2022 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 94 increasing their positions, 66 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.53% less ownership
Funds ownership: 88.18% → 86.64% (-1.5%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
20% less call options, than puts
Call options by funds: $882K | Put options by funds: $1.11M
Holders
241
Holding in Top 10
6
Calls
$882K
Puts
$1.11M
Top Buyers
| 1 | +$38.1M | |
| 2 | +$27.9M | |
| 3 | +$13.8M | |
| 4 |
D.E. Shaw & Co
New York
|
+$9.8M |
| 5 |
Millennium Management
New York
|
+$7.99M |
Top Sellers
| 1 | -$95.8M | |
| 2 | -$43.8M | |
| 3 | -$25.3M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$10.8M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$9.64M |